A breakthrough discovery by scientists at Houston Methodist could change the way we treat cholesterol. Researchers found new evidence that challenges a 40-year notion of how fast we eliminate it from our bodies.
This accidental discovery, made by medical biochemist Henry Pownall, Ph.D., and his team at the Houston Methodist Research Institute, reveals a new pathway in the cholesterol-elimination chain that will be key to developing new drugs to lower cholesterol. Their findings are described in an article titled “ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate,” appearing online Oct. 26 and in print Nov. 21 in the American Heart Association’s Arteriosclerosis, Thrombosis, and Vascular Biology journal.
VIDEO: Dr. Pownall explains the research https://vimeo.com/239663429
Pownall, who is the corresponding author, said the initial purpose of their study was to prove the current model of cholesterol transport through the body was correct. It turns out, however, that the model was not quite right.
“The model people have been using for 40 years presumed that cholesterol was transported from the arteries with other lipids and proteins and entered a particle that stayed in the blood for several days before being cleared by the liver for disposal,” Pownall said. “What we discovered in the process was something different. We discovered the cholesterol skips all these steps and goes directly from this early particle to the liver in two minutes. This is a thousand times faster than what was formerly suspected.”
While most studies look at HDL cholesterol in its mature form found in blood, Pownall and his colleagues studied cholesterol in nascent HDL, an early form of HDL produced by cells. Cholesterol in the nascent HDL goes directly to the liver, largely skipping conversion to the mature form of HDL
Pownall stresses that it’s not that current practices of treating “bad” LDL cholesterol are incorrect, but instead that physicians and researchers need to better understand how the “good” HDL cholesterol contributes to cardiovascular disease and how to raise it in a way that protects the heart, because some patients with very high HDL numbers, which were always thought to be beneficial, are actually at risk.
“LDL cholesterol, the so-called ‘bad cholesterol’ is well controlled with the current statin therapies. The track record for these cholesterol-lowering drugs is indisputable, and they will continue to work,” Pownall said. “HDL, or the ‘good cholesterol,’ however, is a much trickier system. Not everything that raises it protects the heart and not everything that lowers it is bad for you. We will need to redesign new drugs to lower plasma cholesterol in a way that takes into account this new mechanism. We will look for interventions – maybe dietary, maybe pharmacological – that raise HDL cholesterol in a way that helps protect the arteries and prevent cardiovascular disease.”
Researchers collaborating with Pownall on this paper were Bingqing Xu, Baiba K. Gillard, Antonio M. Gotto Jr., and Corina Rosales, and the work was supported by a High-density Lipoprotein (HDL) Biogenesis and Speciation grant from the National Institutes of Health’s National Lung, Heart and Blood Institute (R01HL129767), Deutsche Forschungsgemeinschaft (Exc114-2) and Fondren Foundation.
For more information: ABCA1-Derived Nascent High Density Lipoprotein-Apo AI and Lipids Metabolically Segregate. Arteriosclerosis, Thrombosis, and Vascular Biology DOI: https://doi.org/10.1161/ATVBAHA.117.310290 (Oct. 26, 2017) B. Xu, B.K. Gillard, A.M. Gotto Jr., C. Rosales, H.J. Pownall.
The three focus areas of our Prostate #CancerMoonshot: - overcoming treatment resistance - exploring #immunotherapy - understanding the tumor environment Learn more: https://t.co/0ZQCm8tMdR #PCSM #endcancer
The @GlasscockSchool's fall course catalog is chock-full of offerings for ever-curious learners, including classes in the humanities and sciences, foreign languages and personal and professional development. https://t.co/A793BrcLfz https://t.co/8a1K8LbHE2
Last Shasta County Navy Veteran who survived Pearl Harbor attack laid to rest https://t.co/lc5ODzbk9l via @JimSchultz_RS
One internal medicine resident looks back at a time where a patient helped him realize the balance of overly identifying with patients and complete detachment. https://t.co/7xsFWEhVc4
Santa Clarita Air Force Veteran Launches Campaign For Web Series To Depict Modern Soldier Life https://t.co/Td0ds3jxue via @KHTSRADIO
Today’s #VeteranOfTheDay is @USArmy Veteran Stanley Nelson. https://t.co/SHml8yEysj
Thank you @MBThewoodlands for supporting student scholarships at @MDA_UTHGrad! It also is hosting our next House Calls web chat on sports medicine this Thursday, July 19, at 6:30 p.m. CST at https://t.co/N5UU1Jx4pq. Submit a question for our experts by using #UTHealthHouseCalls.
RT @abc13houston: The most common sports injuries are strains and sprains, but do you know when you might need to see a doctor? The experts…
RT @BCMHouston_News: Tune in to @FOX26Houston tomorrow in the 8 am hour to hear @bcmhouston's Dr. El-Serag discuss the recent CDC report on…
#Cancerpain can be related to the disease and treatment. Hear from Dr. Salahadin Abdi on how patients can find relief. #endcancer https://t.co/snFVjDUjNe
RT @HealthyWomen: 10 Sneaky Ways to Get Fruits and Veggies in Your #Diet: https://t.co/wJ9x39147k #health https://t.co/EWktCmct2J
RT @BCMHouston_News: Certain nail products can cause allergic reactions or irritations. @bcmhouston's Dr. Katta shares what to look out for…
@ParrotsMatter @TargetedOnc @michaelwangmd Hi, yes we are. Here's a list of current clinical trials: https://t.co/JgHpaIKBbX. Best wishes to you.
RT @RiceAthletics: To celebrate #WorldEmojiDay, check out our favorite mascot @SammyTheOwl! 🦉👐 https://t.co/ebIKcsu2Z9
RT @abc13houston: A workout injury can happen to anyone, no matter your experience or fitness level. Learn about treatment options and how…